Ansa Biotechnologies
@ansabio.bsky.social
We’re on a mission to end the headaches of ordering synthetic DNA and give researchers what they really want: reliable DNA, on time, exactly as ordered. #DNASynthesis 🧪
ansabio.com
ansabio.com
What’s possible today with large, complex DNA?
This on-demand webinar walks through a real-world case: a 23 kb dystrophin plasmid synthesized in 20 business days and deployed with AI-guided delivery vehicles.
👉Watch here: hubs.li/Q03Vg1SR0
#DNASynthesis #GeneTherapy
This on-demand webinar walks through a real-world case: a 23 kb dystrophin plasmid synthesized in 20 business days and deployed with AI-guided delivery vehicles.
👉Watch here: hubs.li/Q03Vg1SR0
#DNASynthesis #GeneTherapy
Revolutionizing Gene Therapies through Rapid, Large DNA Synthesis & Designable Delivery Vehicles | Ansa Biotechnologies
On-demand Webinar Register To Watch Breakthroughs in gene therapy depend on the ability to build and deliver large, complex DNA constructs quickly, reliably, and at scale. Yet constructs over 5 kb, or...
hubs.li
February 3, 2026 at 10:08 PM
What’s possible today with large, complex DNA?
This on-demand webinar walks through a real-world case: a 23 kb dystrophin plasmid synthesized in 20 business days and deployed with AI-guided delivery vehicles.
👉Watch here: hubs.li/Q03Vg1SR0
#DNASynthesis #GeneTherapy
This on-demand webinar walks through a real-world case: a 23 kb dystrophin plasmid synthesized in 20 business days and deployed with AI-guided delivery vehicles.
👉Watch here: hubs.li/Q03Vg1SR0
#DNASynthesis #GeneTherapy
Drug Discovery News highlights an exciting advance from New England Bio Labs and Yale University: a synthetic phage engineering platform that enables phages to be designed and built entirely in the lab. Proud that Ansa could deliver the DNA for this study.
www.drugdiscoverynews.com/new-syntheti...
www.drugdiscoverynews.com/new-syntheti...
New synthetic phage platform could reshape antimicrobial therapy
A new system lets researchers build and reprogram phage genomes from digital sequence data, potentially enabling scalable, customizable therapies for drug-resistant bacteria.
www.drugdiscoverynews.com
January 28, 2026 at 11:50 PM
Drug Discovery News highlights an exciting advance from New England Bio Labs and Yale University: a synthetic phage engineering platform that enables phages to be designed and built entirely in the lab. Proud that Ansa could deliver the DNA for this study.
www.drugdiscoverynews.com/new-syntheti...
www.drugdiscoverynews.com/new-syntheti...
ICYMI: Last week’s #JPM event sponsored by Mithrl was a packed house with sharp insights on the future of AI in biology.
Leaders across pharma, biotech & AI, including Jason T. Gammack, shared what will drive the next era of therapeutic discovery.
👉 www.ansabio.com
Leaders across pharma, biotech & AI, including Jason T. Gammack, shared what will drive the next era of therapeutic discovery.
👉 www.ansabio.com
January 22, 2026 at 5:55 PM
ICYMI: Last week’s #JPM event sponsored by Mithrl was a packed house with sharp insights on the future of AI in biology.
Leaders across pharma, biotech & AI, including Jason T. Gammack, shared what will drive the next era of therapeutic discovery.
👉 www.ansabio.com
Leaders across pharma, biotech & AI, including Jason T. Gammack, shared what will drive the next era of therapeutic discovery.
👉 www.ansabio.com
Reposted by Ansa Biotechnologies
ICYMI: We’re partnering with @ansabio.bsky.social to provide customers with access to long, #complexDNA, ranging from 100 bp to 50 kb! Take a look at how this collaboration has delivered value to Manos Papadakis, Senior Research Scientist, @dsmfirmenich.bsky.social. 👇
Read more: idtb.io/c2tiva
Read more: idtb.io/c2tiva
January 21, 2026 at 3:03 PM
ICYMI: We’re partnering with @ansabio.bsky.social to provide customers with access to long, #complexDNA, ranging from 100 bp to 50 kb! Take a look at how this collaboration has delivered value to Manos Papadakis, Senior Research Scientist, @dsmfirmenich.bsky.social. 👇
Read more: idtb.io/c2tiva
Read more: idtb.io/c2tiva
Reposted by Ansa Biotechnologies
New partnership announcement! 🤝
We’re proud to collaborate with @ansabio.bsky.social to provide our customers with access to long, complex #clonalDNA ranging from 100 bp to 50 kb. Read more here: idtb.io/xfs37g
#SyntheticBiology #DNASynthesis #synbio #lifesciencesnews
We’re proud to collaborate with @ansabio.bsky.social to provide our customers with access to long, complex #clonalDNA ranging from 100 bp to 50 kb. Read more here: idtb.io/xfs37g
#SyntheticBiology #DNASynthesis #synbio #lifesciencesnews
January 14, 2026 at 1:29 PM
New partnership announcement! 🤝
We’re proud to collaborate with @ansabio.bsky.social to provide our customers with access to long, complex #clonalDNA ranging from 100 bp to 50 kb. Read more here: idtb.io/xfs37g
#SyntheticBiology #DNASynthesis #synbio #lifesciencesnews
We’re proud to collaborate with @ansabio.bsky.social to provide our customers with access to long, complex #clonalDNA ranging from 100 bp to 50 kb. Read more here: idtb.io/xfs37g
#SyntheticBiology #DNASynthesis #synbio #lifesciencesnews
🚀 Big news: Ansa is partnering with @idtdna.bsky.social to expand access to enzymatic DNA synthesis worldwide. IDT customers can now get sequence-perfect DNA constructs up to 50 kb with the speed and precision researchers trust.
🔗 hubs.ly/Q03-KKPM0
🔗 hubs.ly/Q03-KKPM0
January 14, 2026 at 1:52 PM
🚀 Big news: Ansa is partnering with @idtdna.bsky.social to expand access to enzymatic DNA synthesis worldwide. IDT customers can now get sequence-perfect DNA constructs up to 50 kb with the speed and precision researchers trust.
🔗 hubs.ly/Q03-KKPM0
🔗 hubs.ly/Q03-KKPM0
Attending #JPM26? Don’t miss hearing from Ansa CEO Jason T. Gammack at this JPM Healthcare Satellite Event!
📅 Wed, Jan 14 | 5–8 PM
📍 100 Montgomery St, Ste. 1200, San Francisco
Register: bit.ly/44wDkOZ
Join us for Happy Hour + Panel Discussions on AI & Biopharma Innovation.
#BIOsky #synbio
📅 Wed, Jan 14 | 5–8 PM
📍 100 Montgomery St, Ste. 1200, San Francisco
Register: bit.ly/44wDkOZ
Join us for Happy Hour + Panel Discussions on AI & Biopharma Innovation.
#BIOsky #synbio
January 8, 2026 at 3:09 PM
Attending #JPM26? Don’t miss hearing from Ansa CEO Jason T. Gammack at this JPM Healthcare Satellite Event!
📅 Wed, Jan 14 | 5–8 PM
📍 100 Montgomery St, Ste. 1200, San Francisco
Register: bit.ly/44wDkOZ
Join us for Happy Hour + Panel Discussions on AI & Biopharma Innovation.
#BIOsky #synbio
📅 Wed, Jan 14 | 5–8 PM
📍 100 Montgomery St, Ste. 1200, San Francisco
Register: bit.ly/44wDkOZ
Join us for Happy Hour + Panel Discussions on AI & Biopharma Innovation.
#BIOsky #synbio
Don't wait on slow, unreliable DNA synthesis.
✅ Order whole pathways & multi-gene systems as single constructs
✅ Tackle projects that were once “unsynthesizable”
✅ Design from biology-first principles w/ the confidence that complex constructs will arrive on time & exactly as specified
ansabio.com
✅ Order whole pathways & multi-gene systems as single constructs
✅ Tackle projects that were once “unsynthesizable”
✅ Design from biology-first principles w/ the confidence that complex constructs will arrive on time & exactly as specified
ansabio.com
January 7, 2026 at 4:24 PM
Don't wait on slow, unreliable DNA synthesis.
✅ Order whole pathways & multi-gene systems as single constructs
✅ Tackle projects that were once “unsynthesizable”
✅ Design from biology-first principles w/ the confidence that complex constructs will arrive on time & exactly as specified
ansabio.com
✅ Order whole pathways & multi-gene systems as single constructs
✅ Tackle projects that were once “unsynthesizable”
✅ Design from biology-first principles w/ the confidence that complex constructs will arrive on time & exactly as specified
ansabio.com
🔎 𝗣𝗥𝗘𝗦𝗦 𝗦𝗣𝗢𝗧𝗟𝗜𝗚𝗛𝗧
We are excited to see @GenomeWeb spotlight Ansa and our mission to reshape what is possible in DNA synthesis.
👉 Read the article: hubs.li/Q03YDk7_0
We are excited to see @GenomeWeb spotlight Ansa and our mission to reshape what is possible in DNA synthesis.
👉 Read the article: hubs.li/Q03YDk7_0
December 23, 2025 at 7:13 PM
🔎 𝗣𝗥𝗘𝗦𝗦 𝗦𝗣𝗢𝗧𝗟𝗜𝗚𝗛𝗧
We are excited to see @GenomeWeb spotlight Ansa and our mission to reshape what is possible in DNA synthesis.
👉 Read the article: hubs.li/Q03YDk7_0
We are excited to see @GenomeWeb spotlight Ansa and our mission to reshape what is possible in DNA synthesis.
👉 Read the article: hubs.li/Q03YDk7_0
What would you build with 50 kb of accurate DNA delivered in under a month?
See how @appliedstemcell.bsky.social achieved a precise 50 kb knock-in using TARGATT™ + Ansa DNA synthesis.
📄 bit.ly/49jsX3G 🧪
See how @appliedstemcell.bsky.social achieved a precise 50 kb knock-in using TARGATT™ + Ansa DNA synthesis.
📄 bit.ly/49jsX3G 🧪
December 18, 2025 at 3:38 PM
What would you build with 50 kb of accurate DNA delivered in under a month?
See how @appliedstemcell.bsky.social achieved a precise 50 kb knock-in using TARGATT™ + Ansa DNA synthesis.
📄 bit.ly/49jsX3G 🧪
See how @appliedstemcell.bsky.social achieved a precise 50 kb knock-in using TARGATT™ + Ansa DNA synthesis.
📄 bit.ly/49jsX3G 🧪
In cell and gene therapy, one missing piece can derail your whole project. At Ansa, we deliver complex sequences like ITRs, regulatory regions & long inserts, so you can focus on function, not fabrication.
👉 lnkd.in/gfEe2h4U
🧪 #BIOsky
👉 lnkd.in/gfEe2h4U
🧪 #BIOsky
December 15, 2025 at 11:00 AM
In cell and gene therapy, one missing piece can derail your whole project. At Ansa, we deliver complex sequences like ITRs, regulatory regions & long inserts, so you can focus on function, not fabrication.
👉 lnkd.in/gfEe2h4U
🧪 #BIOsky
👉 lnkd.in/gfEe2h4U
🧪 #BIOsky
Customers deserve the same confidence ordering DNA as any other reagent, says Ansa CEO Jason T Gammack.
In this #SynBioBeta feature, he shares how Ansa delivers >97% fulfillment on long, complex constructs & why the future is shifting from buying genes to buying genomes.
🧪 bit.ly/4iX4qVE
In this #SynBioBeta feature, he shares how Ansa delivers >97% fulfillment on long, complex constructs & why the future is shifting from buying genes to buying genomes.
🧪 bit.ly/4iX4qVE
Ending The Waiting Game: How Ansa Biotechnologies Guarantees are Turning DNA Synthesis Into A Predictable Industry
Join SynBioBeta, the global community of biological engineers, entrepreneurs, investors, and innovators working to make biology easier to engineer.
bit.ly
December 11, 2025 at 12:29 PM
Customers deserve the same confidence ordering DNA as any other reagent, says Ansa CEO Jason T Gammack.
In this #SynBioBeta feature, he shares how Ansa delivers >97% fulfillment on long, complex constructs & why the future is shifting from buying genes to buying genomes.
🧪 bit.ly/4iX4qVE
In this #SynBioBeta feature, he shares how Ansa delivers >97% fulfillment on long, complex constructs & why the future is shifting from buying genes to buying genomes.
🧪 bit.ly/4iX4qVE
𝗡𝗘𝗪 𝗔𝗗𝗗𝗜𝗧𝗜𝗢𝗡 𝗧𝗢 𝗧𝗛𝗘 𝗧𝗘𝗔𝗠: We’re thrilled to announce the appointment of Geoff Hamilton as Ansa’s new Chief Financial Officer and Chief Business Officer.
🔗 Release: hubs.li/Q03Xvjkk0
🔎 Get to know Geoff: hubs.li/Q03Xvj3H0
🔗 Release: hubs.li/Q03Xvjkk0
🔎 Get to know Geoff: hubs.li/Q03Xvj3H0
December 10, 2025 at 4:18 PM
𝗡𝗘𝗪 𝗔𝗗𝗗𝗜𝗧𝗜𝗢𝗡 𝗧𝗢 𝗧𝗛𝗘 𝗧𝗘𝗔𝗠: We’re thrilled to announce the appointment of Geoff Hamilton as Ansa’s new Chief Financial Officer and Chief Business Officer.
🔗 Release: hubs.li/Q03Xvjkk0
🔎 Get to know Geoff: hubs.li/Q03Xvj3H0
🔗 Release: hubs.li/Q03Xvjkk0
🔎 Get to know Geoff: hubs.li/Q03Xvj3H0
Sick of scaling back experiments? We were, too. That’s why we founded a company to reimagine DNA synthesis from the ground up and to fundamentally change the status quo.
🧪 Experience a new kind of DNA provider: hubs.li/Q03grdRG0
#BIOsky #synbio
🧪 Experience a new kind of DNA provider: hubs.li/Q03grdRG0
#BIOsky #synbio
December 7, 2025 at 3:21 PM
Sick of scaling back experiments? We were, too. That’s why we founded a company to reimagine DNA synthesis from the ground up and to fundamentally change the status quo.
🧪 Experience a new kind of DNA provider: hubs.li/Q03grdRG0
#BIOsky #synbio
🧪 Experience a new kind of DNA provider: hubs.li/Q03grdRG0
#BIOsky #synbio
Ordering synthetic DNA? Don’t do it blind.
Get our free guide, which breaks down what to watch for before placing your next order—timelines, QC, complexity, and true cost—so you can make smarter choices with confidence.
👉 hubs.li/Q03WGW7k0
#synbio #BIOsky #syntheticDNA
Get our free guide, which breaks down what to watch for before placing your next order—timelines, QC, complexity, and true cost—so you can make smarter choices with confidence.
👉 hubs.li/Q03WGW7k0
#synbio #BIOsky #syntheticDNA
December 4, 2025 at 4:14 PM
Ordering synthetic DNA? Don’t do it blind.
Get our free guide, which breaks down what to watch for before placing your next order—timelines, QC, complexity, and true cost—so you can make smarter choices with confidence.
👉 hubs.li/Q03WGW7k0
#synbio #BIOsky #syntheticDNA
Get our free guide, which breaks down what to watch for before placing your next order—timelines, QC, complexity, and true cost—so you can make smarter choices with confidence.
👉 hubs.li/Q03WGW7k0
#synbio #BIOsky #syntheticDNA
NOW ON-DEMAND: Webinar for #genetherapy Innovators. featuring a collaboration w/ #EndoFold Bio that generated a full-length ~23 kb human dystrophin plasmid (including UTRs) in ~20 business days .
👉 Watch here: hubs.li/Q03Vg1SR0
#BIOsky #synbio 🧪
👉 Watch here: hubs.li/Q03Vg1SR0
#BIOsky #synbio 🧪
November 25, 2025 at 3:07 PM
NOW ON-DEMAND: Webinar for #genetherapy Innovators. featuring a collaboration w/ #EndoFold Bio that generated a full-length ~23 kb human dystrophin plasmid (including UTRs) in ~20 business days .
👉 Watch here: hubs.li/Q03Vg1SR0
#BIOsky #synbio 🧪
👉 Watch here: hubs.li/Q03Vg1SR0
#BIOsky #synbio 🧪
Scientists no longer need to shrink their imagination to match the limitations of their synthesis suppliers' capabilities. Ansa CEO Jason T Gammack explains how we are flipping the "build vs. buy" equation & making programmable biology programmable.
www.linkedin.com/pulse/dna-sy...
#BIOsky #synbio
www.linkedin.com/pulse/dna-sy...
#BIOsky #synbio
DNA Synthesis Just Hit Its Inflection Point … and Most of the Industry Isn’t Ready
For decades, the DNA synthesis world has operated under a quiet rule: this terrible service is just the way it is. Deal with it.
www.linkedin.com
November 20, 2025 at 10:42 AM
Scientists no longer need to shrink their imagination to match the limitations of their synthesis suppliers' capabilities. Ansa CEO Jason T Gammack explains how we are flipping the "build vs. buy" equation & making programmable biology programmable.
www.linkedin.com/pulse/dna-sy...
#BIOsky #synbio
www.linkedin.com/pulse/dna-sy...
#BIOsky #synbio
🌱 A greener way to make DNA: Ansa uses fully aqueous, enzyme-based synthesis—no harsh chemicals, less waste, and longer, cleaner constructs.
👉Learn more: ansabio.com/technology/?...
#synbio #BIOsky #sustainability #DNAsynthesis
👉Learn more: ansabio.com/technology/?...
#synbio #BIOsky #sustainability #DNAsynthesis
November 18, 2025 at 2:42 PM
🌱 A greener way to make DNA: Ansa uses fully aqueous, enzyme-based synthesis—no harsh chemicals, less waste, and longer, cleaner constructs.
👉Learn more: ansabio.com/technology/?...
#synbio #BIOsky #sustainability #DNAsynthesis
👉Learn more: ansabio.com/technology/?...
#synbio #BIOsky #sustainability #DNAsynthesis
🧪 From 𝗰𝗹𝗼𝗻𝗶𝗻𝗴 to 𝗽𝗿𝗶𝗻𝘁𝗶𝗻𝗴, the field just hit turbo mode. Introducing a PNAS paper in which scientists from Pitt Bio & New England Biolabs worked with Ansa to build fully synthetic mycobacteriophage genomes (viruses) from scratch.
www.pnas.org/doi/10.1073/...
#synbio #BIOsky
www.pnas.org/doi/10.1073/...
#synbio #BIOsky
Genome synthesis, assembly, and rebooting of therapeutically useful high G+C% mycobacteriophages | PNAS
Bacteriophages show therapeutic promise for treating bacterial pathogens including
nontuberculous mycobacteria (NTM). A major impediment is the pau...
www.pnas.org
November 13, 2025 at 2:14 PM
🧪 From 𝗰𝗹𝗼𝗻𝗶𝗻𝗴 to 𝗽𝗿𝗶𝗻𝘁𝗶𝗻𝗴, the field just hit turbo mode. Introducing a PNAS paper in which scientists from Pitt Bio & New England Biolabs worked with Ansa to build fully synthetic mycobacteriophage genomes (viruses) from scratch.
www.pnas.org/doi/10.1073/...
#synbio #BIOsky
www.pnas.org/doi/10.1073/...
#synbio #BIOsky
We are scaling like crazy and have several Manufacturing Associate positions open right now to keep up with the demand.
Please share with anyone who would be interested in joining our team during this exciting time!
job-boards.greenhouse.io/ansabiotechn...
#hiring #manufacturing #sciencejobs
Please share with anyone who would be interested in joining our team during this exciting time!
job-boards.greenhouse.io/ansabiotechn...
#hiring #manufacturing #sciencejobs
Ansa Biotechnologies
<h2>Our Mission:</h2>
<h2><em>Revolutionize the way we make DNA</em></h2>
<p class="">Compared to reading or editing life’s code, writing new code from scratch has remained one of biotechnology’s most...
job-boards.greenhouse.io
November 10, 2025 at 12:58 PM
We are scaling like crazy and have several Manufacturing Associate positions open right now to keep up with the demand.
Please share with anyone who would be interested in joining our team during this exciting time!
job-boards.greenhouse.io/ansabiotechn...
#hiring #manufacturing #sciencejobs
Please share with anyone who would be interested in joining our team during this exciting time!
job-boards.greenhouse.io/ansabiotechn...
#hiring #manufacturing #sciencejobs
𝗡𝗼𝘁𝗵𝗶𝗻𝗴 𝘀𝗽𝗲𝗮𝗸𝘀 𝗹𝗼𝘂𝗱𝗲𝗿 𝘁𝗵𝗮𝗻 𝗰𝘂𝘀𝘁𝗼𝗺𝗲𝗿 𝘀𝘂𝗰𝗰𝗲𝘀𝘀.
We're grateful for this ringing endorsement from Dr. Simon Shu-Yu Wu of @ASCAppliedStem.
👉 Learn more about XL Clonal DNA: ansabio.com/products/50kb/
We're grateful for this ringing endorsement from Dr. Simon Shu-Yu Wu of @ASCAppliedStem.
👉 Learn more about XL Clonal DNA: ansabio.com/products/50kb/
November 6, 2025 at 3:18 PM
𝗡𝗼𝘁𝗵𝗶𝗻𝗴 𝘀𝗽𝗲𝗮𝗸𝘀 𝗹𝗼𝘂𝗱𝗲𝗿 𝘁𝗵𝗮𝗻 𝗰𝘂𝘀𝘁𝗼𝗺𝗲𝗿 𝘀𝘂𝗰𝗰𝗲𝘀𝘀.
We're grateful for this ringing endorsement from Dr. Simon Shu-Yu Wu of @ASCAppliedStem.
👉 Learn more about XL Clonal DNA: ansabio.com/products/50kb/
We're grateful for this ringing endorsement from Dr. Simon Shu-Yu Wu of @ASCAppliedStem.
👉 Learn more about XL Clonal DNA: ansabio.com/products/50kb/
🧪 We are proud to announce the launch of our 50kb Clonal DNA, the longest sequence=perfect synthetic DNA commercially available, in <25 days, backed by the industry's only On-Time Guarantee.
👉 ansabio.com/topic/news-e...
#BIOsky #SyntheticDNA
👉 ansabio.com/topic/news-e...
#BIOsky #SyntheticDNA
October 23, 2025 at 3:58 PM
🧪 We are proud to announce the launch of our 50kb Clonal DNA, the longest sequence=perfect synthetic DNA commercially available, in <25 days, backed by the industry's only On-Time Guarantee.
👉 ansabio.com/topic/news-e...
#BIOsky #SyntheticDNA
👉 ansabio.com/topic/news-e...
#BIOsky #SyntheticDNA
🧬 Finding the right vector just got easier — and faster.
Announcing Ansa’s new Catalog Vectors! Skip the upfront postage & paperwork. Simply upload your sequence file, select your vector, and Ansa will ship your completed DNA to you.
🔗 ansabio.com/products/vec...
Announcing Ansa’s new Catalog Vectors! Skip the upfront postage & paperwork. Simply upload your sequence file, select your vector, and Ansa will ship your completed DNA to you.
🔗 ansabio.com/products/vec...
October 7, 2025 at 11:55 AM
🧬 Finding the right vector just got easier — and faster.
Announcing Ansa’s new Catalog Vectors! Skip the upfront postage & paperwork. Simply upload your sequence file, select your vector, and Ansa will ship your completed DNA to you.
🔗 ansabio.com/products/vec...
Announcing Ansa’s new Catalog Vectors! Skip the upfront postage & paperwork. Simply upload your sequence file, select your vector, and Ansa will ship your completed DNA to you.
🔗 ansabio.com/products/vec...
🚀 We’ve raised $54.4M in an oversubscribed Series B!
This funding powers U.S.-based manufacturing, new products, and the first DNA synthesis on-time guarantee.
🧪 Read the press release: hubs.li/Q03LHN3c0
This funding powers U.S.-based manufacturing, new products, and the first DNA synthesis on-time guarantee.
🧪 Read the press release: hubs.li/Q03LHN3c0
October 1, 2025 at 3:23 PM
🚀 We’ve raised $54.4M in an oversubscribed Series B!
This funding powers U.S.-based manufacturing, new products, and the first DNA synthesis on-time guarantee.
🧪 Read the press release: hubs.li/Q03LHN3c0
This funding powers U.S.-based manufacturing, new products, and the first DNA synthesis on-time guarantee.
🧪 Read the press release: hubs.li/Q03LHN3c0
#DYK: Ansa provides two flexible formats to help accelerate your research potential: sequence-perfect clonal DNA or sequence-verified linear double-stranded DNA fragment formats, both with up-front pricing & guaranteed delivery times.
🧪 ansabio.com/products?utm...
#BIOsky
🧪 ansabio.com/products?utm...
#BIOsky
September 24, 2025 at 4:01 PM
#DYK: Ansa provides two flexible formats to help accelerate your research potential: sequence-perfect clonal DNA or sequence-verified linear double-stranded DNA fragment formats, both with up-front pricing & guaranteed delivery times.
🧪 ansabio.com/products?utm...
#BIOsky
🧪 ansabio.com/products?utm...
#BIOsky